9-35739790-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_020944.3(GBA2):c.1420G>A(p.Ala474Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,613,868 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A474P) has been classified as Uncertain significance.
Frequency
Consequence
NM_020944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GBA2 | NM_020944.3 | c.1420G>A | p.Ala474Thr | missense_variant | 9/17 | ENST00000378103.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GBA2 | ENST00000378103.7 | c.1420G>A | p.Ala474Thr | missense_variant | 9/17 | 1 | NM_020944.3 | P1 | |
GBA2 | ENST00000378094.4 | c.1420G>A | p.Ala474Thr | missense_variant | 9/17 | 1 | |||
GBA2 | ENST00000467252.5 | n.992G>A | non_coding_transcript_exon_variant | 6/13 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.00107 AC: 163AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000494 AC: 124AN: 251040Hom.: 1 AF XY: 0.000346 AC XY: 47AN XY: 135676
GnomAD4 exome AF: 0.000229 AC: 335AN: 1461566Hom.: 1 Cov.: 32 AF XY: 0.000212 AC XY: 154AN XY: 727090
GnomAD4 genome ? AF: 0.00106 AC: 162AN: 152302Hom.: 0 Cov.: 32 AF XY: 0.00101 AC XY: 75AN XY: 74468
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.1420G>A (p.A474T) alteration is located in exon 9 (coding exon 9) of the GBA2 gene. This alteration results from a G to A substitution at nucleotide position 1420, causing the alanine (A) at amino acid position 474 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Nov 01, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2023 | GBA2: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at